Everolimus-eluting stent platforms in percutaneous coronary intervention: comparative effectiveness and outcomes

References

• GrüntzigARSenningÅSiegenthalerWENonoperative dilatation of coronary-artery stenosisN Engl J Med197930126168449946
   PubMed Web of Science ®Google Scholar
• NabelEGBraunwaldEA tale of coronary artery disease and myocardial infarctionN Engl J Med20123661546322216842
   PubMed Web of Science ®Google Scholar
• FischmanDLLeonMBBaimDSA randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study InvestigatorsN Engl J Med199433184965018041414
   PubMed Web of Science ®Google Scholar
• SerruysPWde JaegerePKiemeneijFA comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study GroupN Engl J Med199433184894958041413
   PubMed Web of Science ®Google Scholar
• MoriceMCSerruysPWSousaJEA randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularizationN Engl J Med2002346231773178012050336
   PubMed Web of Science ®Google Scholar
• JonerMFinnAVFarbAPathology of drug-eluting stents in humans: delayed healing and late thrombotic riskJ Am Coll Cardiol200648119320216814667
   PubMed Web of Science ®Google Scholar
• MenownIBNoadRGarciaEJMeredithIThe platinum chromium element stent platform: from alloy, to design, to clinical practiceAdv Ther201027312914120437213
   PubMed Web of Science ®Google Scholar
• IqbalJOnumaYOrmistonJAbizaidAWaksmanRSerruysPBioresorbable scaffolds: rationale, current status, challenges, and futureEur Heart J2014351276577624366915
   PubMed Web of Science ®Google Scholar
• O’BrienBJStinsonJSLarsenSREppihimerMJCarrollWMA platinum-chromium steel for cardiovascular stentsBiomaterials201031143755376120181394
   PubMed Web of Science ®Google Scholar
• StoneGWTeirsteinPSMeredithITA prospective, randomized evaluation of a novel everolimus-eluting coronary stent: the PLATINUM (A prospective, randomized, multicenter trial to assess an everolimus-eluting coronary stent system [promus element] for the treatment of up to Two De Novo Coronary Artery Lesions) TrialJ Am Coll Cardiol201157161700170821470815
   PubMed Web of Science ®Google Scholar
• ThomasMRBirkemeyerRSchwimmbeckPOne-year outcomes in 1,010 unselected patients treated with the PROMUS Element everolimus-eluting stent: the multicentre PROMUS Element European Post-Approval Surveillance StudyEuroIntervention201510111267127125631367
   PubMed Web of Science ®Google Scholar
• OrmistonJAWebberBUbodBWhiteJWebsterMWCoronary stent durability and fracture: an independent bench comparison of six contemporary designs using a repetitive bend testEuroIntervention201510121449145525420788
   PubMed Web of Science ®Google Scholar
• GogasBDFarooqVOnumaYSerruysPWThe ABSORB bioresorbable vascular scaffold: an evolution or revolution in interventional cardiology?Hellenic J Cardiol201253430130922796817
   PubMed Web of Science ®Google Scholar
• WeltFGRogersCInflammation and restenosis in the stent eraArterioscler Thromb Vasc Biol200222111769177612426203
   PubMed Web of Science ®Google Scholar
• CostaMASimonDIMolecular basis of restenosis and drug-eluting stentsCirculation2005111172257227315867193
   PubMed Web of Science ®Google Scholar
• CarterAJTOR of the cell cycle: are there important implications for diabetics in the era of the drug-eluting stent?Catheter Cardiovasc Interv200461223323614755819
   PubMed Web of Science ®Google Scholar
• SchulerWSedraniRCottensSSDZ RAD, a new rapamycin derivative: pharmacological properties in vitro and in vivoTransplantation199764136429233698
   PubMed Web of Science ®Google Scholar
• EisenHJTuzcuEMDorentREverolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipientsN Engl J Med2003349984785812944570
   PubMed Web of Science ®Google Scholar
• VerheyeSMartinetWKockxMMSelective clearance of macrophages in atherosclerotic plaques by autophagyJ Am Coll Cardiol200749670671517291937
   PubMed Web of Science ®Google Scholar
• KahanBDWongRLCarterCA phase I study of a 4-week course of SDZ-RAD (RAD) quiescent cyclosporine-prednisone-treated renal transplant recipientsTransplantation19996881100110610551636
   PubMed Web of Science ®Google Scholar
• RogersCDOptimal stent design for drug deliveryRev Cardiovasc Med20045Suppl 2S9S1515184829
   PubMedGoogle Scholar
• KotaniJAwataMNantoSIncomplete neointimal coverage of sirolimus-eluting stents: angioscopic findingsJ Am Coll Cardiol200647102108211116697331
   PubMed Web of Science ®Google Scholar
• FinnAVJonerMNakazawaGPathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelializationCirculation2007115182435244117438147
   PubMed Web of Science ®Google Scholar
• DaemenJWenaweserPTsuchidaKEarly and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort studyLancet2007369956266767817321312
   PubMed Web of Science ®Google Scholar
• CarterAJBrodeurACollingwoodRExperimental efficacy of an everolimus eluting cobalt chromium stentCatheter Cardiovasc Interv20066819710316755598
   PubMed Web of Science ®Google Scholar
• WindeckerSKolhPAlfonsoF2014 ESC/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI)Eur Heart J201435372541261925173339
   PubMed Web of Science ®Google Scholar
• GrubeESonodaSIkenoFSix- and twelve-month results from first human experience using everolimus-eluting stents with bioabsorbable polymerCirculation2004109182168217115123533
   PubMed Web of Science ®Google Scholar
• CostaRALanskyAJMintzGSAngiographic results of the first human experience with everolimus-eluting stents for the treatment of coronary lesions (the FUTURE I trial)Am J Cardiol200595111311615619406
   PubMed Web of Science ®Google Scholar
• TsuchiyaYLanskyAJCostaRAEffect of everolimus-eluting stents in different vessel sizes (from the pooled FUTURE I and II trials)Am J Cardiol200698446446916893698
   PubMed Web of Science ®Google Scholar
• SerruysPWOngATPiekJJA randomized comparison of a durable polymer everolimus-eluting stent with a bare metal coronary stent: the SPIRIT first trialEuroIntervention200511586519758878
   PubMedGoogle Scholar
• TsuchidaKPiekJJNeumannFJOne-year results of a durable polymer everolimus-eluting stent in de novo coronary narrowings (The SPIRIT FIRST Trial)EuroIntervention20051326627219758915
   PubMedGoogle Scholar
• BeijkMANeumannFJWiemerMTwo-year results of a durable polymer everolimus-eluting stent in de novo coronary artery stenosis (The SPIRIT FIRST Trial)EuroIntervention20073220621219758939
   PubMedGoogle Scholar
• de BelderAde la Torre HernandezJMLopez-PalopRA prospective randomized trial of everolimus-eluting stents versus bare-metal stents in octogenarians: the XIMA Trial (Xience or vision stents for the management of angina in the elderly)J Am Coll Cardiol201463141371137524216285
   PubMed Web of Science ®Google Scholar
• SabateMBrugalettaSCequierAThe EXAMINATION trial (everolimus-eluting stents versus bare-metal stents in ST-segment elevation myocardial infarction): 2-year results from a multicenter randomized controlled trialJACC Cardiovasc Interv201471647124332423
   PubMed Web of Science ®Google Scholar
• KaiserCGalatiusSErnePDrug-eluting versus bare-metal stents in large coronary arteriesN Engl J Med2010363242310231921080780
   PubMed Web of Science ®Google Scholar
• ValgimigliMSabateMKaiserCEffects of cobalt-chromium everolimus eluting stents or bare metal stent on fatal and non-fatal cardiovascular events: patient level meta-analysisBMJ2014349g642725378023
   PubMed Web of Science ®Google Scholar
• SerruysPWRuygrokPNeuznerJA randomised comparison of an everolimus-eluting coronary stent with a paclitaxel-eluting coronary stent: the SPIRIT II trialEuroIntervention20062328629419755303
   PubMedGoogle Scholar
• OnumaYMiquel-HebertKSerruysPWFive-year long-term clinical follow-up of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with de novo coronary artery disease: the SPIRIT II trialEuroIntervention2013891047105123339811
   PubMed Web of Science ®Google Scholar
• StoneGWMideiMNewmanWComparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trialJAMA2008299161903191318430909
   PubMed Web of Science ®Google Scholar
• GadaHKirtaneAJNewmanW5-year results of a randomized comparison of XIENCE V everolimus-eluting and TAXUS paclitaxel-eluting stents: final results from the SPIRIT III trial (clinical evaluation of the XIENCE V everolimus eluting coronary stent system in the treatment of patients with de novo native coronary artery lesions)JACC Cardiovasc Interv20136121263126624239202
   PubMed Web of Science ®Google Scholar
• StoneGWRizviANewmanWEverolimus-eluting versus paclitaxel-eluting stents in coronary artery diseaseN Engl J Med2010362181663167420445180
   PubMed Web of Science ®Google Scholar
• StoneGA large scale randomized comparison of everolimus-eluting and paclitaxel-eluting stents: three-year outcomes from the SPIRIT IV trialPresented at Transcatheter Cardiovascular TherapeuticsSan Francisco, CA, USANovember 7–11, 2011
   Google Scholar
• SmitsPCKedhiERoyaardsKJ2-year follow-up of a randomized controlled trial of everolimus- and paclitaxel-eluting stents for coronary revascularization in daily practice. COMPARE (Comparison of the everolimus eluting XIENCE-V stent with the paclitaxel eluting TAXUS LIBERTE stent in all-comers: a randomized open label trial)J Am Coll Cardiol2011581111821514083
   PubMed Web of Science ®Google Scholar
• KedhiEJoesoefKSMcFaddenESecond-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trialLancet2010375971020120920060578
   PubMed Web of Science ®Google Scholar
• TandjungKSenHLamMKClinical outcome following stringent discontinuation of dual antiplatelet therapy after 12 months in real-world patients treated with second-generation zotarolimus-eluting resolute and everolimus-eluting Xience V stents: 2-year follow-up of the random-ized TWENTE trialJ Am Coll Cardiol201361242406241623602769
   PubMed Web of Science ®Google Scholar
• von BirgelenCSenHLamMKThird-generation zotarolimus-eluting and everolimus-eluting stents in all-comer patients requiring a percutaneous coronary intervention (DUTCH PEERS): a randomised, single-blind, multicentre, non-inferiority trialLancet2014383991541342324183564
   PubMed Web of Science ®Google Scholar
• SerruysPWSilberSGargSComparison of zotarolimus-eluting and everolimus-eluting coronary stentsN Engl J Med2010363213614620554978
   PubMed Web of Science ®Google Scholar
• MiyazakiTLatibAPanoulasVFComparison of 2-year outcomes between zotarolimus-eluting and everolimus-eluting new-generation cobalt-chromium alloy stents in real-world diabetic patientsCatheter Cardiovasc Interv2015861E11E1825534499
   PubMed Web of Science ®Google Scholar
• PiccoloRStefaniniGGFranzoneASafety and efficacy of resolute zotarolimus-eluting stents compared with everolimus-eluting stents: a meta-analysisCirc Cardiovasc Interv201584
   PubMed Web of Science ®Google Scholar
• JensenLOThayssenPHansenHSRandomized comparison of everolimus-eluting and sirolimus-eluting stents in patients treated with percutaneous coronary intervention: the Scandinavian organization for randomized trials with clinical outcome IV (SORT OUT IV)Circulation2012125101246125522308301
   PubMed Web of Science ®Google Scholar
• ParkD-WKimY-HSongH-GComparison of everolimus- and sirolimus-Eluting stents in patients with long coronary artery lesions: a randomized LONG-DES-III (percutaneous treatment of LONG native coronary lesions with drug-eluting stent-III) trialJACC Cardiovasc Interv20114101096110322017935
   PubMed Web of Science ®Google Scholar
• ParkKWChaeI-HLimD-SEverolimus-eluting versus sirolimus-eluting stents in patients undergoing percutaneous coronary intervention: the EXCELLENT (efficacy of XIENCE/Promus versus Cypher to reduce late loss after stenting) randomized trialJ Am Coll Cardiol201158181844185422018294
   PubMed Web of Science ®Google Scholar
• KimW-JLeeS-WParkS-WRandomized comparison of everolimus-eluting stent versus sirolimus-eluting stent implantation for De Novo coronary artery disease in patients with diabetes mellitus (ESSENCE-DIABETES): results from the ESSENCE-DIABETES trialCirculation2011124888689221810659
   PubMed Web of Science ®Google Scholar
• WindeckerSHaudeMNeumannFJComparison of a novel biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent: results of the randomized BIOFLOW-II trialCirc Cardiovasc Interv201582e00144125634905
   PubMed Web of Science ®Google Scholar
• PilgrimTHegDRoffiMUltrathin strut biodegradable polymer sirolimus-eluting stent versus durable polymer everolimus-eluting stent for percutaneous coronary revascularisation (BIOSCIENCE): a randomised, single-blind, non-inferiority trialLancet201438499602111212225189359
   PubMed Web of Science ®Google Scholar
• HofmaSHSmitsPCBrouwerJLong-term follow-up of second-generation everolimus-eluting stents versus first-generation sirolimus-eluting stents in acute myocardial infarction: three-year results of the XAMI trialEuroIntervention201510111280128325572025
   PubMed Web of Science ®Google Scholar
• Di LorenzoESauroRVarricchioARandomized comparison of everolimus-eluting stents and sirolimus-eluting stents in patients with ST elevation myocardial infarction: RACES-MI trialJACC Cardiovasc Interv20147884985625147029
   PubMed Web of Science ®Google Scholar
• ToyotaTShiomiHMorimotoTKimuraTMeta-analysis of long-term clinical outcomes of everolimus-eluting stentsAm J Cardiol2015116218719425960378
   PubMed Web of Science ®Google Scholar
• BaberUMehranRSharmaSKImpact of the everolimus-eluting stent on stent thrombosis: a meta-analysis of 13 randomized trialsJ Am Coll Cardiol201158151569157721924575
   PubMed Web of Science ®Google Scholar
• ParkKWKangSHKangHJA randomized comparison of platinum chromium-based everolimus-eluting stents versus cobalt chromium-based zotarolimus-eluting stents in all-comers receiving percutaneous coronary intervention: HOST-ASSURE (harmonizing optimal strategy for treatment of coronary artery stenosis-safety and effectiveness of drug-eluting stents and anti-platelet regimen), a randomized, controlled, noninferiority trialJ Am Coll Cardiol20146325 pt A2805281624814486
   PubMed Web of Science ®Google Scholar
• KereiakesDJMeredithITWindeckerSEfficacy and safety of a novel bioabsorbable polymer-coated, everolimus-eluting coronary stent: the EVOLVE II randomized trialCirc Cardiovasc Interv201584
   Web of Science ®Google Scholar
• GaoRHanYYangYPLATINUM China: a prospective, ran-domized investigation of the platinum chromium everolimus-eluting stent in de novo coronary artery lesionsCatheter Cardiovasc Interv201585Suppl 171672325631909
   PubMed Web of Science ®Google Scholar
• StefaniniGGKalesanBSerruysPWLong-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer sirolimus-eluting stents in patients with coronary artery disease (LEADERS): 4 year follow-up of a randomised non-inferiority trialLancet201137898071940194822075451
   PubMed Web of Science ®Google Scholar
• SimsekCKaranasosAMagroMLong-term invasive followup of the everolimus-eluting bioresorbable vascular scaffold: five-year results of multiple invasive imaging modalitiesEuroIntervention2014201307240325349042
   PubMed Web of Science ®Google Scholar
• BourantasCVFarooqVZhangYCircumferential distribution of the neointima at six-month and two-year follow-up after a bioresorbable vascular scaffold implantation: a substudy of the ABSORB Cohort B Clinical TrialEuroIntervention201510111299130624769420
   PubMed Web of Science ®Google Scholar
• SerruysPWChevalierBDudekDA bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trialLancet20153859962435425230593
   PubMed Web of Science ®Google Scholar
• PuricelSArroyoDCorpatauxNComparison of everolimus- and biolimus-eluting coronary stents with everolimus-eluting bioresorbable vascular scaffoldsJ Am Coll Cardiol201565879180125720622
   PubMed Web of Science ®Google Scholar
• CostopoulosCLatibANaganumaTComparison of early clinical outcomes between ABSORB bioresorbable vascular scaffold and everolimus-eluting stent implantation in a real-world populationCatheter Cardiovasc Interv2015851E10E1524909303
   PubMed Web of Science ®Google Scholar
• CapodannoDGoriTNefHPercutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registryEuroIntervention201510101144115325042421
   PubMed Web of Science ®Google Scholar
• KraakRPHassellMEGrundekenMDInitial experience and clinical evaluation of the absorb bioresorbable vascular scaffold (BVS) in real-world practice: the AMC single centre real world PCI registryEuroIntervention201510101160116825136885
   PubMed Web of Science ®Google Scholar
• van GeunsRJBVS expand: 6-month resultsPresented at: EuroPCR2014 Available from: http://www.pcronline.com/Lectures/2014/BVS-Expand-6-month-results
   Google Scholar
• WoehrleJNaberCSchmitzTBeyond the ealy stages: insights from the ASSURE Registry on bioresorbable vascular scaffoldEuroIntervention201511214915625499836
   PubMed Web of Science ®Google Scholar
• EeckhoutESethAMaoVMABSORB FIRST: an interim report on baseline characteristics and acute performance on the first 1,200 patients from a prospective, multi-center, global registryJ Am Coll Cardiol20146411_S679
   Web of Science ®Google Scholar
• BrugalettaSGoriTLowAFAbsorb bioresorbable vascular scaffold versus everolimus-eluting metallic stent in ST-segment elevation myocardial infarction: 1-year results of a propensity score matching comparison: the BVS-EXAMINATION Study (bioresorbable vascular scaffold-a clinical evaluation of everolimus eluting coronary stents in the treatment of patients with ST-segment elevation myocardial infarction)JACC Cardiovasc Interv201581 pt B18919725616924
   PubMed Web of Science ®Google Scholar
• PanoulasVFMiyazakiTKawamotoHColomboAChieffoABioresorbable scaffolds for the treatment of complex lesions: are we there yet?Interv Cardiol2015713554
   Google Scholar
• PanoulasVFMiyazakiTSatoKProcedural outcomes of patients with calcified lesions treated with bioresorbable vascular scaffoldsEuroIntervention20151011201411210125868742
   PubMed Web of Science ®Google Scholar
• IelasiALatibANaganumaTEarly results following everolimus-eluting bioresorbable vascular scaffold implantation for the treatment of in-stent restenosisInt J Cardiol2014173351351424717326
   PubMed Web of Science ®Google Scholar
• IshibashiYNakataniSOnumaYDefinite and probable bioresorbable scaffold thrombosis in stable and ACS patientsEuroIntervention Epub9222014
   Web of Science ®Google Scholar
• ParkS-JAhnJ-MKimY-HTrial of everolimus-eluting stents or bypass surgery for coronary diseaseN Engl J Med2015372131204121225774645
   PubMed Web of Science ®Google Scholar
• BangaloreSGuoYSamadashviliZBleckerSXuJHannanELEverolimus-eluting stents or bypass surgery for multivessel coronary diseaseN Engl J Med2015372131213122225775087
   PubMed Web of Science ®Google Scholar
• DangasGDSerruysPWKereiakesDJMeta-analysis of everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease: final 3-year results of the SPIRIT clinical trials program (Clinical evaluation of the Xience V everolimus eluting coronary stent system in the treatment of patients with De Novo Native Coronary Artery Lesions)JACC Cardiovasc Interv20136991492224050859
   PubMed Web of Science ®Google Scholar